Dr. William Gray, System Chief of the Division of Cardiovascular Disease at Main Line Health and President of Lankenau Heart Institute, will serve as a keynote speaker at the Complex Cardiovascular Catheter Therapeutics Advanced Endovascular and Coronary Intervention Global Summit (C3) Conference, being held from June 28-July 1, 2016, in Orlando, Florida. Dr. Gray’s lecture will focus on three therapies: carotid stenting, patent foramen ovale (PFO) closure, and left atrial appendage occlusion.
“I am honored to have the opportunity to share information about the innovative cardiac care we are providing at Lankenau Heart Institute, helping to advance the field of cardiovascular medicine across the globe,” says Dr. Gray, an interventional cardiologist and nationally recognized leader in endovascular and structural cardiac medicine. “From research and diagnostics, to treatment, rehabilitation and disease management, the entire Lankenau Heart Institute and Main Line Health team continually look for new preventive measures and treatment options to offer superior outcomes to our patients in the Philadelphia region and beyond.”
Dr. Gray has been instrumental in growing the field of endovascular therapies and structural cardiac intervention through clinical training, program development, and device research. He has served as principal investigator for more than 50 clinical trials of coronary, endovascular and structural heart interventions. In the past 10 years, Dr. Gray has led several clinical studies leading to FDA approval or clearance for new interventional devices. His contributions to scientific literature include more than 100 peer reviewed journal articles, several book chapters, and the co-authored textbook, Vascular Medicine: Therapy and Practice, now in its second edition. He serves on the editorial board of JACC Cardiac Interventions and is a reviewer for several other peer-reviewed cardiovascular publications.
About Lankenau Heart Institute
The Lankenau Heart Institute is Main Line Health's premier, comprehensive cardiovascular medicine and surgery program. Lankenau Heart Institute brings together the clinical expertise of all four Main Line Health acute care hospitals and community cardiology practices to ensure that patients receive a level of quality, service, and experience that is unprecedented in the region. Through the system-wide coordination of services, Lankenau Heart Institute delivers preventive, diagnostic, therapeutic, and rehabilitative cardiovascular services at each of our locations including Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital.
Lankenau Heart Institute continues to be an innovator in the use of beating-heart techniques and robotic-assisted procedures for coronary artery revascularization, minimally invasive and transcatheter approaches for valve repair and replacement, complex aortic surgery and heart rhythm disorders. With our growing experience and focus on minimally invasive techniques, Lankenau Heart Institute has expanded participation in clinical trials year over year. Our physicians are frequently invited to participate in clinical/medical device trials, many of these designed to facilitate and expand the use of minimally invasive approaches and procedures.
With a collaborative team of expert consultative cardiologists, interventional cardiologists, electrophysiologists, cardiovascular surgeons and specially trained advance practice nurses and technologists, Lankenau Heart Institute is dedicated to managing and treating patients with simple to complex cardiovascular disease, including heart failure, aortic disease, coronary and peripheral vascular disease, heart rhythm disorders and valve disease. Our team of cardiologists and cardiac specialists provide patients and their families with expert cardiac care, close to home.
About Main Line Health
Founded in 1985, Main Line Health is a not-for-profit health system serving Philadelphia and its western suburbs. Main Line Health's commitment—to deliver advanced medicine for treating and curing disease, playing an important role in prevention and disease management as well as training physicians and other health care providers—reflects our intent to be the region's premier choice for clinical care, research, and education. A team of more than 10,000 employees, 3,000 nurses and 2,000 physicians care for patients throughout the Main Line Health System.
At Main Line Health's core are four of the region's most respected acute care hospitals—Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital—as well as one of the nation's premier facilities for rehabilitative medicine, Bryn Mawr Rehabilitation Hospital.
Main Line Health also includes Mirmont Treatment Center for drug and alcohol recovery; Main Line Health HomeCare & Hospice, which includes skilled home health care, hospice and home infusion services; Main Line Health Centers, primary and specialty care, lab and radiology, and other outpatient services located in Broomall, Collegeville, Concordville, Exton, King of Prussia and Newtown Square; Lankenau Institute for Medical Research, a biomedical research organization; and Main Line HealthCare, one of the region's largest multispecialty physician networks.
Main Line Health is the recipient of numerous awards for quality care, and service, including U.S. News & World Report's Best Hospitals, System Magnet® designation; the nation's highest distinction for nursing excellence and the Mid-Atlantic Alliance for Performance Excellence (MAAPE) Excellence Award. Main Line Health is committed to creating an environment of diversity, respect, equity, and inclusion, has proudly received awards in this area and has embraced the American Hospital Association's #123forEquity Pledge to Act to eliminate disparities in care. We are dedicated to advancing patient-centered care, education, and research to help patients stay healthy and live their best lives.
For more information, visit mainlinehealth.org and connect with us on social media: